美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA125289"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
57894-070-89 57894-070 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20090425 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 50 mg/.5mL 1 SYRINGE in 1 CARTON (57894-070-89) / .5 mL in 1 SYRINGE
57894-070-90 57894-070 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20090425 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 50 mg/.5mL 1 SYRINGE, GLASS in 1 CARTON (57894-070-90) / .5 mL in 1 SYRINGE, GLASS
57894-071-01 57894-071 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20130515 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 100 mg/mL 1 SYRINGE, GLASS in 1 CARTON (57894-071-01) / 1 mL in 1 SYRINGE, GLASS
57894-070-02 57894-070 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20090425 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 50 mg/.5mL 1 SYRINGE in 1 CARTON (57894-070-02) / .5 mL in 1 SYRINGE
57894-070-01 57894-070 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20090425 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 50 mg/.5mL 1 SYRINGE, GLASS in 1 CARTON (57894-070-01) / .5 mL in 1 SYRINGE, GLASS
57894-071-89 57894-071 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20130515 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 100 mg/mL 1 SYRINGE in 1 CARTON (57894-071-89) / 1 mL in 1 SYRINGE
57894-071-02 57894-071 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20130515 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 100 mg/mL 1 SYRINGE in 1 CARTON (57894-071-02) / 1 mL in 1 SYRINGE
57894-071-90 57894-071 HUMAN PRESCRIPTION DRUG Simponi golimumab INJECTION, SOLUTION SUBCUTANEOUS 20130515 N/A BLA BLA125289 Janssen Biotech, Inc. GOLIMUMAB 100 mg/mL 1 SYRINGE, GLASS in 1 CARTON (57894-071-90) / 1 mL in 1 SYRINGE, GLASS
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase